PharmaACE
BDL Solutions

Due diligence for potential pipeline asset acquisition

Due diligence for potential pipeline asset acquisition
March 6, 20262.4K views
1

Objective

  • Conduct due diligence to assess a pipeline asset of interest for potential acquisition
2

Approach

  • Phase 1: Foundational secondary desk research of market and disease landscape
  • Phase 2: Qualitative interviews about Target Product Profile (TPP) of focused asset
  • Phase 3: Sales force sizing for commercial launch
  • Phase 4: IP Analysis
  • Phase 5: Forecast revenues to test commercial viability
3

Outcome

  • Arrived at details about patient journey, treatment paradigm, competitive landscape and epidemiology triangulation
  • Conducted primary market research to understand KOL and Payer reactions to TPP
  • Estimated market reach and time to peak of product share
  • Executed revenue tree built on IP decision tree analytics
  • Built revenue forecast model and analyzed sensitivities on key commercial drivers
4

Client Benefits

  • This analysis helped the client gain insights into access constraints within a generics-dominated market
  • The IP analysis provided market data that helped the client create effective business rules for future projects
  • Based on our recommendation, the client avoided investing in a later-stage commercially-failed product, protecting resources and mitigating potential losses